Melola Discovery

← Melola Discovery

Jurnal SINTA 1

BASAL INSULIN AS ADD-ON THERAPY TO ORAL GLUCOSE-LOWERING DRUGS IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS IN PRIMARY PUBLIC HEALTH CENTER

Folia Medica Indonesiana · Vol. 49 No. 2 (2013)

ISSN
2355-8393, 2599-056X
Terbit
2013-04-01
Penerbit
Airlangga University
Bahasa
en

Abstrak

Effective glycemic control is very important to minimize longterm complications of type 2 diabetes mellitus (DM). However, it is welldocumented that many patients spend prolonged periods above optimal glycaemic range, especially in primary public health centers.Most of primary care physicians, who are responsible to manage them, delay to iniate insulin therapy for some reasons. The aim ofthis study was to evaluate efficacy and safety of insulin detemir added to oral therapy in insulin-naive individuals with type 2 DM.This one group pre- and post-test study involved insulin-naive and previously oral-treated DM patients (n=64, HbA1c> 8.0%),drawn from 10 primary public health center centers all over Surabaya, Indonesia, using simple random sampling method. Patientswere treated with insulin detemir for 12 weeks and insulin doses were titrated to target fasting plasma glucose (FPG) < 125 mg/dl.Outcomes evaluated included HbA1c, level of fasting and 2 hours post-prandial glucose, risk of hypoglycemia and body weight. After12 weeks, HbA1c had decreased by 2.53% (from 11.38% to 8.85%) with detemir insulin once a day (p=0.001). FPG improved from201.75 mg/dl to 152.47 mg/dl (p=0.001) and 2 hour post-prandial glucose improved from 287.91 mg/dl to 222.30 mg/dl (p=0.001).Frequency of hypoglycaemia events were 6.4% (4 hypoglycaemic events) and all cases were mild events so that they did not need tobe admitted in the hospital. Hypoglycaemic events can be treated by the patients themselves with sugar and food intake, and then thedose of detemir insulin was adjusted. Besides hypoglyecemic events, no other side effects were recorded. Mean the pre insulintherapy BMI was 23.94 ± 4.22 kg/m2 to become 23.34 ± 5.60 kg/m 2 at the end of the study. There was a decrease in body weightbefore and after insulin detemir therapy, but it was not statistically significant (p 0.37, 95% CI -0.74-1.95). In conclusion, theaddition of basal insulin to oral antidiabetic drugs in poorly controlled type 2 diabetes patients in primary public health centerachieved clinically improvements in glycaemic control with low risks of hypoglycaemia and non-significant body weightincrease.(FMI 2013;49 128-133)

Kata kunci

Jaringan kolaborasi para penulis

19 penulis · 38 tautan kepenulisan bersama · 19 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • University of Brawijaya
  • Hasanuddin University
  • Rumah Sakit Dokter Soetomo
  • Universitas Hang Tuah
  • Muhammadiyah University of Yogyakarta
  • Universitas Gadjah Mada
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Wahiduddin WahiduddinHasanuddin University3
Sudjarwo SudjarwoUniversitas Airlangga3
Robert Dwitama AdiwinotoUniversitas Airlangga1
Titong SugihartonoUniversitas Airlangga1
Soebagijo Adi SoelistijoRumah Sakit Dokter Soetomo1
Ronald Pratama AdiwinotoUniversitas Hang Tuah1
Tri WahyuliatiMuhammadiyah University of Yogyakarta1
Samekto WibowoUniversitas Gadjah Mada1
Lilik HerawatiUniversitas Airlangga1
Indira SyahrayaUniversitas Airlangga1
Purwo Sri RejekiUniversitas Airlangga1
Adeodatus Yuda HandayaRumah Sakit Umum Pusat Dr. Sardjito1
Djanggan SargowoUniversity of Brawijaya1
Diana LyrawatiUniversity of Brawijaya1
Mohammad Aris WidodoUniversity of Brawijaya1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">BASAL INSULIN AS ADD-ON THERAPY TO ORAL GLUCOSE-LOWERING DRUGS IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS IN PRIMARY PUBLIC HEALTH CENTER</dc:title><dc:creator>Hermina Novida</dc:creator><dc:creator>Agung Sindu Pranoto</dc:creator><dc:creator>Jongky Hendro Prayitno</dc:creator><dc:creator>Askandar Tjokroprawiro</dc:creator><dc:subject>insulin detemir</dc:subject><dc:subject>basal insulin</dc:subject><dc:subject>adjunctive therapy</dc:subject><dc:subject>type 2 diabetes</dc:subject><dc:subject>insulin-naive patients</dc:subject><dc:subject>oral glucose-lowering agents</dc:subject><dc:subject>glycemic control</dc:subject><dc:subject>HbA1c</dc:subject><dc:subject>hypoglycemia</dc:subject><dc:subject>body weight</dc:subject><dc:subject>primary care</dc:subject><dc:subject>fasting blood glucose</dc:subject><dc:subject>postprandial blood glucose</dc:subject><dc:subject>insulin dose adjustment</dc:subject><dc:subject>Surabaya</dc:subject><dc:subject>public health centers</dc:subject><dc:description xml:lang="en">Effective glycemic control is very important to minimize longterm complications of type 2 diabetes mellitus (DM). However, it is welldocumented that many patients spend prolonged periods above optimal glycaemic range, especially in primary public health centers.Most of primary care physicians, who are responsible to manage them, delay to iniate insulin therapy for some reasons. The aim ofthis study was to evaluate efficacy and safety of insulin detemir added to oral therapy in insulin-naive individuals with type 2 DM.This one group pre- and post-test study involved insulin-naive and previously oral-treated DM patients (n=64, HbA1c&gt; 8.0%),drawn from 10 primary public health center centers all over Surabaya, Indonesia, using simple random sampling method. Patientswere treated with insulin detemir for 12 weeks and insulin doses were titrated to target fasting plasma glucose (FPG) &lt; 125 mg/dl.Outcomes evaluated included HbA1c, level of fasting and 2 hours post-prandial glucose, risk of hypoglycemia and body weight. After12 weeks, HbA1c had decreased by 2.53% (from 11.38% to 8.85%) with detemir insulin once a day (p=0.001). FPG improved from201.75 mg/dl to 152.47 mg/dl (p=0.001) and 2 hour post-prandial glucose improved from 287.91 mg/dl to 222.30 mg/dl (p=0.001).Frequency of hypoglycaemia events were 6.4% (4 hypoglycaemic events) and all cases were mild events so that they did not need tobe admitted in the hospital. Hypoglycaemic events can be treated by the patients themselves with sugar and food intake, and then thedose of detemir insulin was adjusted. Besides hypoglyecemic events, no other side effects were recorded. Mean the pre insulintherapy BMI was 23.94 ± 4.22 kg/m2 to become 23.34 ± 5.60 kg/m 2 at the end of the study. There was a decrease in body weightbefore and after insulin detemir therapy, but it was not statistically significant (p 0.37, 95% CI -0.74-1.95). In conclusion, theaddition of basal insulin to oral antidiabetic drugs in poorly controlled type 2 diabetes patients in primary public health centerachieved clinically improvements in glycaemic control with low risks of hypoglycaemia and non-significant body weightincrease.(FMI 2013;49 128-133)</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2013-04-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/filerPDF/fmi5887bc14e8full.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 49 No 2 (2013)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>